SWKH News and Press, SWK Holdings Corporation From 08/17/20

SWK Holdings (NASDAQ: SWKH ) : Q2 GAAP EPS of $0.07 beats by $0.14 . More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, , Read more ...

DALLAS , Aug. 17, 2020 /PRNewswire/ -- Corporate Highlights Rajiv Khosla , Ph.D. appointed as Chief Executive Officer of Enteris BioPharma Repurchased $1.0 million of common stock during the three-month span ended June 30, 2020 SWK Holdings Added to Russell 3000™, 2...

DALLAS , Aug. 14, 2020 /PRNewswire/ --  SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live audio webcast on Monday, August 17, 2020 , at 10:00 a.m. ET , to discuss its corporate...

NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive ...

DALLAS , June 29, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today its addition to the broad-market Russell 3000 ®   Index, the Russell   2000 ®   Index and the Russell Mic...

The following slide deck was published by SWK Holdings Corporation in conjunction with this Read more ...

DALLAS , June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will present via webcast at the Life Sciences Investor Forum being held June 25, 2020 . Details of SWK...

NEW YORK, June 23, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentatio...

BOONTON, N.J. , June 9, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that John Vretto...

BOONTON, N.J. , June 2, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is pa...